143 related articles for article (PubMed ID: 38644608)
1. Critical roles of long noncoding RNA H19 in cancer.
Darmadi D; Chugaeva UY; Saleh RO; Hjazi A; Saleem HM; Ghildiyal P; Alwaily ER; Alawadi A; Alnajar MJ; Ihsan A
Cell Biochem Funct; 2024 Apr; 42(3):e4018. PubMed ID: 38644608
[TBL] [Abstract][Full Text] [Related]
2. LncRNA H19: A novel oncogene in multiple cancers.
Yang J; Qi M; Fei X; Wang X; Wang K
Int J Biol Sci; 2021; 17(12):3188-3208. PubMed ID: 34421359
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells.
Yan L; Yang S; Yue CX; Wei XY; Peng W; Dong ZY; Xu HN; Chen SL; Wang WR; Chen CJ; Yang QL
Environ Toxicol; 2020 Sep; 35(9):1015-1028. PubMed ID: 32420678
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of long noncoding RNA H19 indicates a poor prognosis for cholangiocarcinoma and promotes cell migration and invasion by affecting epithelial-mesenchymal transition.
Xu Y; Wang Z; Jiang X; Cui Y
Biomed Pharmacother; 2017 Aug; 92():17-23. PubMed ID: 28528181
[TBL] [Abstract][Full Text] [Related]
5. lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA.
Lv M; Zhong Z; Huang M; Tian Q; Jiang R; Chen J
Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1887-1899. PubMed ID: 28779971
[TBL] [Abstract][Full Text] [Related]
6. HHLA2 promotes tumor progression by long non‑coding RNA H19 in human gallbladder cancer.
Zhang Y; Li H; Lv C; Wu B; Yu Y; Zhong C; Lang Q; Liang Z; Li Y; Shi Y; Zhang J; Xu F; Tian Y
Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35920182
[TBL] [Abstract][Full Text] [Related]
7. The Effect of LncRNA H19/miR-194-5p Axis on the Epithelial-Mesenchymal Transition of Colorectal Adenocarcinoma.
Li CF; Li YC; Wang Y; Sun LB
Cell Physiol Biochem; 2018; 50(1):196-213. PubMed ID: 30278464
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA H19 is responsible for the progression of lung adenocarcinoma by mediating methylation-dependent repression of CDH1 promoter.
Gao LM; Xu SF; Zheng Y; Wang P; Zhang L; Shi SS; Wu T; Li Y; Zhao J; Tian Q; Yin XB; Zheng L
J Cell Mol Med; 2019 Sep; 23(9):6411-6428. PubMed ID: 31317666
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Long Noncoding RNA H19 Downregulates miR-140-5p and Activates PI3K/AKT Signaling Pathway to Promote Invasion, Migration and Epithelial-Mesenchymal Transition of Ovarian Cancer Cells.
Xu H; Ding Y; Yang X
Biomed Res Int; 2021; 2021():6619730. PubMed ID: 34250088
[TBL] [Abstract][Full Text] [Related]
10. Long non‑coding RNA H19 regulates cell growth and metastasis via the miR‑22‑3p/Snail1 axis in gastric cancer.
Gan L; Lv L; Liao S
Int J Oncol; 2019 Jun; 54(6):2157-2168. PubMed ID: 31081061
[TBL] [Abstract][Full Text] [Related]
11. LncRNA H19/miR-194/PFTK1 axis modulates the cell proliferation and migration of pancreatic cancer.
Sun Y; Zhu Q; Yang W; Shan Y; Yu Z; Zhang Q; Wu H
J Cell Biochem; 2019 Mar; 120(3):3874-3886. PubMed ID: 30474270
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA Linc00152 is involved in cell cycle arrest, apoptosis, epithelial to mesenchymal transition, cell migration and invasion in gastric cancer.
Zhao J; Liu Y; Zhang W; Zhou Z; Wu J; Cui P; Zhang Y; Huang G
Cell Cycle; 2015; 14(19):3112-23. PubMed ID: 26237576
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B1.
Zhang Y; Huang W; Yuan Y; Li J; Wu J; Yu J; He Y; Wei Z; Zhang C
J Exp Clin Cancer Res; 2020 Jul; 39(1):141. PubMed ID: 32698890
[TBL] [Abstract][Full Text] [Related]
14. SNHG6 is upregulated in primary breast cancers and promotes cell cycle progression in breast cancer-derived cell lines.
Jafari-Oliayi A; Asadi MH
Cell Oncol (Dordr); 2019 Apr; 42(2):211-221. PubMed ID: 30826970
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA H19 participates in metformin-mediated inhibition of gastric cancer cell invasion.
Li P; Tong L; Song Y; Sun J; Shi J; Wu Z; Diao Y; Li Y; Wang Z
J Cell Physiol; 2019 Apr; 234(4):4515-4527. PubMed ID: 30192003
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA H19 regulates HIF-1α/AXL signaling through inhibiting miR-20b-5p in endometrial cancer.
Zhu H; Jin YM; Lyu XM; Fan LM; Wu F
Cell Cycle; 2019 Oct; 18(19):2454-2464. PubMed ID: 31411527
[TBL] [Abstract][Full Text] [Related]
17. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
18. From junk to master regulators of invasion: lncRNA functions in migration, EMT and metastasis.
Dhamija S; Diederichs S
Int J Cancer; 2016 Jul; 139(2):269-80. PubMed ID: 26875870
[TBL] [Abstract][Full Text] [Related]
19. LncRNA H19 Promoted the Epithelial to Mesenchymal Transition and Metastasis in Gastric Cancer via Activating Wnt/β-Catenin Signaling.
Liu J; Wang G; Zhao J; Liu X; Zhang K; Gong G; Pan H; Jiang Z
Dig Dis; 2022; 40(4):436-447. PubMed ID: 34348271
[TBL] [Abstract][Full Text] [Related]
20. LncRNA PTCSC3 inhibits triple-negative breast cancer cell proliferation by downregulating lncRNA H19.
Wang N; Hou M; Zhan Y; Sheng X
J Cell Biochem; 2019 Sep; 120(9):15083-15088. PubMed ID: 31026090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]